Jo Ann Johnson
Papers
1
Total Citations
3
H-Index
1
About
Dr. Jo Ann Johnson is a leading voice in perioperative pain management, with a focused expertise in multimodal analgesia and opioid-sparing strategies for urologic surgery. Her most notable contribution is a landmark 2023 quality improvement study that investigated the use of buprenorphine as an alternative to conventional opioids for patients undergoing robotic-assisted laparoscopic prostatectomy. This work directly addresses the critical challenge of mitigating perioperative opioid exposure, offering a safer, effective pathway for pain control while reducing the risk of opioid-related adverse effects and dependence. Though early in its citation history, this study has already garnered 3 citations, signaling its growing influence in reshaping clinical protocols. Dr. Johnson’s research is pivotal for surgeons and anesthesiologists seeking to implement evidence-based, patient-centered pain management in minimally invasive procedures. Her work not only advances surgical recovery but also contributes to the broader public health effort to combat the opioid crisis, positioning her as a key innovator in the field of perioperative medicine.
Research Focus
Key Achievements
Top Papers
- 1